Literature DB >> 25387303

Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study.

Gaku Takahashi1, Shigehiro Shibata, Hiroyasu Ishikura, Masanao Miura, Yasuo Fukui, Yoshihiro Inoue, Shigeatsu Endo.   

Abstract

BACKGROUND: Few prospective studies have described the prognostic accuracy of presepsin for 28-day mortality during days 0 to 7, or its role in the diagnosis of disseminated intravascular coagulation (DIC) in patients with infection.
OBJECTIVE: We aimed to evaluate the clinical usefulness of presepsin levels by comparing infection markers such as procalcitonin, interleukin-6 and C-reactive protein, as well as markers of DIC such as fibrin degradation products (FDPs) and D-dimer, from days 0 to 7.
DESIGN: A prospective, multicentre, observational study.
SETTING: Four medical institutions between June 2010 and June 2011. PATIENTS: A total of 191 patients who fulfilled at least one of the systemic inflammatory response syndrome (SIRS) criteria were enrolled in the study. MAIN OUTCOME MEASURES: The presepsin levels were evaluated for their diagnostic accuracy in discriminating between SIRS and sepsis, the prognostic accuracy for 28-day mortality from days 0 to 7 and the diagnostic accuracy for DIC in patients with infection by comparison with other infection markers.
RESULTS: The diagnostic accuracy for discriminating between SIRS and sepsis from combining the presepsin and procalcitonin measurements [area under the curve (AUC), 0.91; likelihood ratio, 4.96] was higher than that of presepsin (AUC, 0.89; likelihood ratio, 4.75) or procalcitonin (AUC, 0.85; likelihood ratio, 3.18) alone. Not only the correlation coefficient between the presepsin level and the sequential organ failure assessment (SOFA) score but also the prognostic accuracy of presepsin for 28-day mortality increased with the elapsed time, and both were highest at day 7. The diagnostic accuracy for DIC generated by combining presepsin and FDP (AUC, 0.84; likelihood ratio, 3.57) was higher than that of FDP (AUC, 0.82; likelihood ratio, 2.64) or presepsin (AUC, 0.80; likelihood ratio, 2.94) alone.
CONCLUSION: The prognosis and severity of infection may be assessed more accurately by measuring the presepsin levels until day 7. Presepsin is a useful diagnostic tool for DIC with infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25387303     DOI: 10.1097/EJA.0000000000000178

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  10 in total

1.  Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis.

Authors:  Xiaomeng Tong; Yongtong Cao; Min Yu; Chengwu Han
Journal:  Ther Clin Risk Manag       Date:  2015-07-02       Impact factor: 2.423

2.  The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis.

Authors:  Zhongjun Zheng; Libing Jiang; Ligang Ye; Yuzhi Gao; Luping Tang; Mao Zhang
Journal:  Ann Intensive Care       Date:  2015-12-08       Impact factor: 6.925

3.  Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.

Authors:  Yong Liu; Jun-Huan Hou; Qing Li; Kui-Jun Chen; Shu-Nan Wang; Jian-Min Wang
Journal:  Springerplus       Date:  2016-12-12

4.  Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis.

Authors:  Chin-Chieh Wu; Hao-Min Lan; Shih-Tsung Han; Chung-Hsien Chaou; Chun-Fu Yeh; Su-Hsun Liu; Chih-Huang Li; Gerald N Blaney; Zhen-Ying Liu; Kuan-Fu Chen
Journal:  Ann Intensive Care       Date:  2017-09-06       Impact factor: 6.925

5.  Presepsin levels in cirrhotic patients with bacterial infections and/or portal hypertension-related bleeding, presenting with or without acute kidney injury.

Authors:  Ioannis Elefsiniotis; Stefanos A Tsakiris; Georgia Barla; Athanasia Tasovasili; Dimitrios Vrachatis; Christos Mavrogiannis
Journal:  Ann Gastroenterol       Date:  2018-07-18

6.  The Association between Dynamic Changes in Serum Presepsin Levels and Mortality in Immunocompromised Patients with Sepsis: A Prospective Cohort Study.

Authors:  Jongmin Lee; Seohyun Kim; Kyung Hoon Kim; Na Ri Jeong; Seok Chan Kim; Eun-Jee Oh
Journal:  Diagnostics (Basel)       Date:  2021-01-02

Review 7.  Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis.

Authors:  Dimitrios Velissaris; Nicholas Zareifopoulos; Vasileios Karamouzos; Evangelos Karanikolas; Charalampos Pierrakos; Ioanna Koniari; Menelaos Karanikolas
Journal:  Cureus       Date:  2021-05-13

Review 8.  The Pathogenesis of Sepsis and Potential Therapeutic Targets.

Authors:  Min Huang; Shaoli Cai; Jingqian Su
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

9.  Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study.

Authors:  Jun Chen; Ze-Bing Huang; Hai Li; Xin Zheng; Jin-Jun Chen; Xian-Bo Wang; Zhi-Ping Qian; Xiao-Xiao Liu; Xue-Gong Fan; Xing-Wang Hu; Cheng-Jin Liao; Li-Yuan Long; Yan Huang
Journal:  Infect Dis Ther       Date:  2020-11-04

10.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.